COVID-19 相关皮肤损伤：下肢罕见大水疱
COVID-19 Wounds: Unusual Lower Extremity Bullae.
机构信息
Montefiore Medical Center, Bronx, NY, USA.
出版信息
Int J Low Extrem Wounds. 2023 Mar;22(1):130-134. doi: 10.1177/1534734620964284. Epub 2020 Oct 20.
Abstract
As the COVID-19 pandemic emerged, skin manifestations have been reported as part of this disease's multisystem manifestations. While a rash similar to chilblains in acral distribution has been the most commonly reported complication, we noted a pattern of more severe lower extremity skin complications, specifically large bullae, in a series of COVID-19 patients.
摘要
随着 COVID-19 大流行的出现，皮肤表现已被报告为本病多系统表现的一部分。虽然肢端分布类似于冻疮样疹的皮疹是最常报告的并发症，但我们注意到一系列 COVID-19 患者出现了更严重的下肢皮肤并发症，特别是大疱。
相似文献
1
COVID-19 Wounds: Unusual Lower Extremity Bullae.
Int J Low Extrem Wounds. 2023 Mar;22(1):130-134. doi: 10.1177/1534734620964284. Epub 2020 Oct 20.
2
COVID 19-associated chilblain-like acral lesions among children and adolescents: an Italian retrospective, multicenter study.
Ital J Dermatol Venerol. 2023 Apr;158(2):117-123. doi: 10.23736/S2784-8671.23.07539-4.
3
Purple toes following critical COVID-19 infection.
Pediatr Dermatol. 2022 Sep;39(5):815-817. doi: 10.1111/pde.15075.
4
Lessons From the First Wave of the Pandemic: Skin Features of COVID-19 Can Be Divided Into Inflammatory and Vascular Patterns [Formula: see text].
J Cutan Med Surg. 2021 Mar-Apr;25(2):169-176. doi: 10.1177/1203475420972343. Epub 2020 Nov 12.
5
Long-term Outcome of Chilblains Associated with SARS-CoV-2.
Acta Derm Venereol. 2021 Dec 13;101(12):adv00614. doi: 10.2340/00015555-3930.
6
Cutaneous Manifestations of COVID-19 in the Lower Limbs: A Narrative Review.
Int J Environ Res Public Health. 2022 Jul 21;19(14):8861. doi: 10.3390/ijerph19148861.
7
Fulminant Hemorrhagic Bullae of the Upper Extremities Arising in the Setting of IV Placement During Severe COVID-19 Infection: Observations From a Major Consultative Practice.
Cutis. 2021 Jul;108(1):E31-E33. doi: 10.12788/cutis.0326.
8
Chilblain-like lesions with prominent bullae in a patient with COVID-19.
BMJ Case Rep. 2020 Nov 2;13(11):e237917. doi: 10.1136/bcr-2020-237917.
9
Evolution of incidence of chilblain-like lesions in children during the first year of COVID-19 pandemic.
Pediatr Dermatol. 2022 Mar;39(2):243-249. doi: 10.1111/pde.14948. Epub 2022 Feb 7.
10
SARS-CoV-2 endothelial infection causes COVID-19 chilblains: histopathological, immunohistochemical and ultrastructural study of seven paediatric cases.
Br J Dermatol. 2020 Oct;183(4):729-737. doi: 10.1111/bjd.19327. Epub 2020 Aug 5.
引用本文的文献
1
Post-surgical pyoderma gangrenosum in otherwise healthy patient with history of COVID-19.
Breast J. 2021 Aug;27(8):671-674. doi: 10.1111/tbj.14242. Epub 2021 May 24.
2
COVID-19 Toes and Other Skin Lesions During the Pandemic: Emerging Entities?
Int J Low Extrem Wounds. 2022 Dec;21(4):658-660. doi: 10.1177/15347346211011843. Epub 2021 Apr 23.
3
Unmasking Peripheral Arterial Disease in Diabetic Patients Presenting With Inflammatory Skin Manifestations During the COVID-19 Pandemic.
Int J Low Extrem Wounds. 2022 Sep;21(3):344-345. doi: 10.1177/15347346211004029. Epub 2021 Apr 15.
4
Time of Onset of Selected Skin Lesions Associated with COVID-19: A Systematic Review.
Dermatol Ther (Heidelb). 2021 Jun;11(3):695-705. doi: 10.1007/s13555-021-00526-8. Epub 2021 Apr 2.
本文引用的文献
1
Classification of the cutaneous manifestations of COVID-19: a rapid prospective nationwide consensus study in Spain with 375 cases.
Br J Dermatol. 2020 Jul;183(1):71-77. doi: 10.1111/bjd.19163. Epub 2020 Jun 10.
2
Hypercoagulability of COVID-19 patients in intensive care unit: A report of thromboelastography findings and other parameters of hemostasis.
J Thromb Haemost. 2020 Jul;18(7):1738-1742. doi: 10.1111/jth.14850. Epub 2020 Jun 24.
3
Prominent changes in blood coagulation of patients with SARS-CoV-2 infection.
Clin Chem Lab Med. 2020 Jun 25;58(7):1116-1120. doi: 10.1515/cclm-2020-0188.
Zotero 插件